Literature DB >> 24264047

Large intestine permeability is increased in patients with compensated liver cirrhosis.

Kirsten E Pijls1, Ger H Koek, Elhaseen E Elamin, Hanne de Vries, Ad A M Masclee, Daisy M A E Jonkers.   

Abstract

Intestinal barrier dysfunction, facilitating translocation of bacteria and bacterial products, plays an important role in the pathophysiology of liver cirrhosis and its complications. Increased intestinal permeability has been found in patients with liver cirrhosis, but data on small and large intestine permeability and tight junctions (TJs) in patients with compensated cirrhosis are scarce. We aimed to investigate both small and large intestine permeability in patients with stable compensated cirrhosis compared with healthy controls and evaluated the expression of TJ proteins in mucosal biopsies at duodenal and sigmoid level. Intestinal permeability was assessed in 26 patients with compensated cirrhosis and 27 matched controls using a multisugar test. Duodenal and sigmoid biopsies were available from a subgroup for analyses of gene transcription and expression of key TJ proteins by qRT-PCR and ELISA, respectively. Median 0-5-h urinary sucrose excretion and lactulose/rhamnose ratio were comparable between patients with compensated cirrhosis and controls, whereas 5-24-h urinary sucralose/erythritol ratio was increased in these patients. Downregulation of gene transcription was found for claudin-3 in duodenal biopsies and claudin-4 in sigmoid biopsies, and at the protein level occludin expression was significantly increased in both duodenal and sigmoid biopsies. This study shows that gastroduodenal and small intestine permeability are not altered, whereas large intestine permeability is increased in patients with stable compensated cirrhosis. Only limited alterations were found regarding the expression of TJ proteins in both the small and large intestine.

Entities:  

Keywords:  complications; intestinal epithelial barrier; liver cirrhosis; permeability; tight junctions

Mesh:

Substances:

Year:  2013        PMID: 24264047     DOI: 10.1152/ajpgi.00330.2013

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  18 in total

1.  Thirty-eight-negative kinase 1 mediates trauma-induced intestinal injury and multi-organ failure.

Authors:  Milena Armacki; Anna Katharina Trugenberger; Ann K Ellwanger; Tim Eiseler; Christiane Schwerdt; Lucas Bettac; Dominik Langgartner; Ninel Azoitei; Rebecca Halbgebauer; Rüdiger Groß; Tabea Barth; André Lechel; Benjamin M Walter; Johann M Kraus; Christoph Wiegreffe; Johannes Grimm; Annika Scheffold; Marlon R Schneider; Kenneth Peuker; Sebastian Zeißig; Stefan Britsch; Stefan Rose-John; Sabine Vettorazzi; Eckhart Wolf; Andrea Tannapfel; Konrad Steinestel; Stefan O Reber; Paul Walther; Hans A Kestler; Peter Radermacher; Thomas Fe Barth; Markus Huber-Lang; Alexander Kleger; Thomas Seufferlein
Journal:  J Clin Invest       Date:  2018-10-15       Impact factor: 14.808

Review 2.  Methods to determine intestinal permeability and bacterial translocation during liver disease.

Authors:  Lirui Wang; Cristina Llorente; Phillipp Hartmann; An-Ming Yang; Peng Chen; Bernd Schnabl
Journal:  J Immunol Methods       Date:  2015-01-13       Impact factor: 2.303

Review 3.  Liver cirrhosis and immune dysfunction.

Authors:  Elda Hasa; Phillipp Hartmann; Bernd Schnabl
Journal:  Int Immunol       Date:  2022-09-06       Impact factor: 5.071

Review 4.  Circadian Rhythms Coordinated With Gut Microbiota Partially Account for Individual Differences in Hepatitis B-Related Cirrhosis.

Authors:  Tongyao Wang; Xingyu Rong; Chao Zhao
Journal:  Front Cell Infect Microbiol       Date:  2022-07-01       Impact factor: 6.073

5.  Increased Small Intestinal Permeability during Severe Acute Exacerbations of COPD.

Authors:  Roy T M Sprooten; Kaatje Lenaerts; Dionne C W Braeken; Ilvy Grimbergen; Erica P Rutten; Emiel F M Wouters; Gernot G U Rohde
Journal:  Respiration       Date:  2018-01-25       Impact factor: 3.580

6.  Colonic inflammation and secondary bile acids in alcoholic cirrhosis.

Authors:  Genta Kakiyama; Phillip B Hylemon; Huiping Zhou; William M Pandak; Douglas M Heuman; Dae Joong Kang; Hajime Takei; Hiroshi Nittono; Jason M Ridlon; Michael Fuchs; Emily C Gurley; Yun Wang; Runping Liu; Arun J Sanyal; Patrick M Gillevet; Jasmohan S Bajaj
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-03       Impact factor: 4.052

Review 7.  Changes of Intestinal Functions in Liver Cirrhosis.

Authors:  Hiroshi Fukui; Reiner Wiest
Journal:  Inflamm Intest Dis       Date:  2016-03-08

Review 8.  Intestinal permeability in a patient with liver cirrhosis.

Authors:  Jonathan Manuel Aguirre Valadez; Liliana Rivera-Espinosa; Osvely Méndez-Guerrero; Juan Luis Chávez-Pacheco; Ignacio García Juárez; Aldo Torre
Journal:  Ther Clin Risk Manag       Date:  2016-11-18       Impact factor: 2.423

Review 9.  Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review.

Authors:  Toru Shizuma
Journal:  World J Hepatol       Date:  2018-02-27

Review 10.  Gut Microbiota and Host Reaction in Liver Diseases.

Authors:  Hiroshi Fukui
Journal:  Microorganisms       Date:  2015-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.